XiMed

Présentation de l’entreprise

XiMed aims, by exploiting a PATENTED PHASE CONTRAST imaging technology, to revolutionize the clinical workflow for the early detection of breast cancer by accurately qualifying microcalcifications directly on mammogram images, thus avoiding unnecessary macrobiopsies for millions of patients.